Skip to main content

Closed

PRTA: Prothena Corporation plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-217.9%

ROIC-39.4%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio10.43×

Prothena Corporation plc

PRTANASDAQ·USD·Closed

Prothena Corporation plc

PRTANASDAQ·USD·Closed

$8.12

−3.45%

$8.12

−$0.29 (3.45%)

52W Range

29thpctl

Volume

0.91×avg

Mkt Cap

425.11MUSD

P/E

-2.9TTM

Div Yield

–ann

52W Range

29thpctl

Volume

0.91×avg

Market Cap

425.11MUSD

P/E Ratio

-2.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings